VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,531,000 | +519.8% | 194,800 | +324.4% | 0.02% | +566.7% |
| Q1 2018 | $731,000 | -90.5% | 45,900 | -87.5% | 0.00% | -90.9% |
| Q4 2017 | $7,708,000 | +125.1% | 368,617 | +53.9% | 0.03% | +120.0% |
| Q3 2017 | $3,425,000 | -74.3% | 239,525 | -68.8% | 0.02% | -75.0% |
| Q2 2017 | $13,346,000 | +23314.0% | 768,929 | +14977.0% | 0.06% | – |
| Q1 2017 | $57,000 | -94.4% | 5,100 | -92.7% | 0.00% | -100.0% |
| Q4 2016 | $1,009,000 | -90.3% | 69,500 | -83.7% | 0.01% | -90.4% |
| Q3 2016 | $10,411,000 | +177.8% | 425,100 | +127.5% | 0.05% | +173.7% |
| Q2 2016 | $3,748,000 | +4527.2% | 186,884 | +5928.5% | 0.02% | – |
| Q1 2016 | $81,000 | -72.4% | 3,100 | +6.9% | 0.00% | -100.0% |
| Q4 2015 | $293,000 | -25.1% | 2,900 | +31.8% | 0.00% | 0.0% |
| Q3 2015 | $391,000 | -34.7% | 2,200 | -18.5% | 0.00% | -33.3% |
| Q2 2015 | $599,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |